These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36673651)

  • 1. Creation and Validation of the European Portuguese Version of the Systemic Lupus Erythematous Quality of Life Questionnaire.
    Ferreira PL; Cunha RN; Macieira C; Fontes T; Inês LS; Maduro A; Martins A; Rajão F; Furtado C; Barcelos A
    Int J Environ Res Public Health; 2023 Jan; 20(2):. PubMed ID: 36673651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation and the associated factors of the Malay version of systemic lupus erythematosus-specific health-related quality of life questionnaires (SLEQoL and LupusQoL).
    Ahmad Pouzi NA; Shaharir SS; Mohd Tamil A; Mustafar R; Ahmad Maulana S; Mageswaren E; Wan Ghazali WS
    PLoS One; 2023; 18(5):e0285461. PubMed ID: 37186611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translation into Brazilian Portuguese, cultural adaptation and validatation of the systemic lupus erythematosus quality of life questionnaire (SLEQOL).
    Freire EA; Bruscato A; Leite DR; Sousa TT; Ciconelli RM
    Acta Reumatol Port; 2010; 35(3):334-9. PubMed ID: 20975636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The reliability, validity and responsiveness of the Thai version of Systemic Lupus Erythematosus Quality of Life (SLEQOL-TH) instrument.
    Kasitanon N; Wangkaew S; Puntana S; Sukitawut W; Leong KP; ; Louthrenoo W
    Lupus; 2013 Mar; 22(3):289-96. PubMed ID: 23358871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Chinese version of the SLEQOL is a reliable assessment of health-related quality of life in Han Chinese patients with systemic lupus erythematosus.
    Jiang HZ; Lin ZG; Li HJ; -Du Q; -Tian W; Wang SY; Guan SQ; Mei YF
    Clin Rheumatol; 2018 Jan; 37(1):151-160. PubMed ID: 29168029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-cultural adaptation and validation of Systemic Lupus Erythematosus Quality of Life questionnaire into Arabic.
    Aziz MM; Galal MAA; Elzohri MH; El-Nouby F; Leong KP
    Lupus; 2018 Apr; 27(5):780-787. PubMed ID: 29308728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Arabic LupusPRO: A Cross-Cultural Validation of a Disease-Specific Patient-Reported Outcome Tool for Quality of Life in Lupus Patients.
    Elkaraly NE; Nasef SI; Omar AS; Fouad AM; Jolly M; Mohamed AE
    Lupus; 2020 Nov; 29(13):1727-1735. PubMed ID: 32878556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related quality of life in portuguese SLE patients: an outcome measure independent of disease activity and cumulative damage.
    Duarte C; Abreu P; Couto M; Vaz C; Malcata A; Inês L
    Acta Reumatol Port; 2010; 35(1):30-5. PubMed ID: 20518146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of performance of specific (SLEQOL) and generic (SF36) health-related quality of life questionnaires and their associations with disease status of systemic lupus erythematosus: a longitudinal study.
    Louthrenoo W; Kasitanon N; Morand E; Kandane-Rathnayake R
    Arthritis Res Ther; 2020 Jan; 22(1):8. PubMed ID: 31924267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and preliminary validation of a systemic lupus erythematosus-specific quality-of-life instrument (SLEQOL).
    Leong KP; Kong KO; Thong BY; Koh ET; Lian TY; Teh CL; Cheng YK; Chng HH; Badsha H; Law WG; Lau TC; Chew LC; Ho HJ; Pong LY; Hoi LS; Sangeetha N; Chan SP; Howe HS
    Rheumatology (Oxford); 2005 Oct; 44(10):1267-76. PubMed ID: 15797980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the Portuguese Version of the Scleroderma Health Assessment Questionnaire.
    Genrinho I; Ferreira PL; Santiago T; Carones A; Mazeda C; Barcelos A; Beirão T; Costa F; Santos I; Couto M; Rato M; Terroso G; Monteiro P
    Int J Environ Res Public Health; 2023 Nov; 20(22):. PubMed ID: 37998293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validity and reliability of the Lupus QoL index in Turkish systemic lupus erythematosus patients.
    Pamuk ON; Onat AM; Donmez S; Mengüs C; Kisacik B
    Lupus; 2015 Jul; 24(8):816-21. PubMed ID: 25542903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Rheumatology Attitudes Index and its helplessness subscale are valid and reliable measures of learned helplessness in Asian patients with systemic lupus erythematosus.
    Thumboo J; Fong KY; Chan SP; Leong KH; Feng PH; Thio ST; Boey ML
    J Rheumatol; 1999 Jul; 26(7):1512-7. PubMed ID: 10405938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The validity and reliability of Systemic Lupus Erythematosus Quality of Life Questionnaire (L-QoL) in a Turkish population.
    Duruöz MT; Unal C; Toprak CS; Sezer I; Yilmaz F; Ulutatar F; Atagündüz P; Baklacioglu HS
    Lupus; 2017 Dec; 26(14):1528-1533. PubMed ID: 28467289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of a disease-specific health-related quality of life measure in adult Italian patients with systemic lupus erythematosus: LupusQoL-IT.
    Conti F; Perricone C; Reboldi G; Gawlicki M; Bartosiewicz I; Pacucci VA; Massaro L; Miranda F; Truglia S; Alessandri C; Spinelli FR; Teh LS; Ceccarelli F; Valesini G
    Lupus; 2014 Jul; 23(8):743-51. PubMed ID: 24569393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged clinical remission and low disease activity statuses are associated with better quality of life in systemic lupus erythematosus.
    Poomsalood N; Narongroeknawin P; Chaiamnuay S; Asavatanabodee P; Pakchotanon R
    Lupus; 2019 Sep; 28(10):1189-1196. PubMed ID: 31307256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of belimumab therapy on the quality of life in patients with systemic lupus erythematosus: A cohort study.
    Prete M; Susca N; Leone P; De Giacomo A; Bray A; Brunori G; Favoino E; Perosa F; Racanelli V
    Lupus; 2023 Nov; 32(13):1528-1535. PubMed ID: 37903488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the MOS SF-36 for quality of life assessment of patients with systemic lupus erythematosus in Singapore.
    Thumboo J; Fong KY; Ng TP; Leong KH; Feng PH; Thio ST; Boey ML
    J Rheumatol; 1999 Jan; 26(1):97-102. PubMed ID: 9918248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adaptation and validation of the Bulgarian version of the Systemic Lupus Erythematosus Quality of Life Questionnaire (L-QoL).
    Pencheva DT; Coffey A; McKenna SP; Monov SV
    Clin Rheumatol; 2023 Jul; 42(7):1811-1817. PubMed ID: 36913029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a disease-specific health-related quality of life measure, the LupusQol, for adults with systemic lupus erythematosus.
    McElhone K; Abbott J; Shelmerdine J; Bruce IN; Ahmad Y; Gordon C; Peers K; Isenberg D; Ferenkeh-Koroma A; Griffiths B; Akil M; Maddison P; Teh LS
    Arthritis Rheum; 2007 Aug; 57(6):972-9. PubMed ID: 17665467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.